by Administrators Qynapse | Feb 3, 2020 | News
QyScore® allows automated quantification of a broad portfolio of Magnetic Resonance Imaging markers that are key to support early diagnosis and clinical monitoring of neurodegenerative disorders PARIS, France, Feb 3. 2020 — QYNAPSE, a medical technology company,...
by Administrators Qynapse | Jul 1, 2019 | News
From July 14 – 18th, Qynapse will be part of the 2019 Alzheimer’s Association International Conference (AAIC®) held in Los Angeles, California. For the second time, Qynapse will present at the AAI Conference – the largest global forum to advance dementia science. The...
by Administrators Qynapse | Apr 11, 2019 | News
QyScore®, the software by Qynapse that provides automated volumetric measurements of brain structures, takes a big step forward with the validation of performance for one of its major functionalities. The validation study (conducted in 2018) focuses on the performance...
by Administrators Qynapse | Feb 25, 2019 | News
Qynapse took part in the 2019 International Conference on Alzheimer’s & Parkinson’s Disease (AD/PD™)in Lisbon, Portugal from March 26 – 31st. The AD/PD™ conference, which attracts over 3,000 participants worldwide, almost reached 4,000 attendants this year –...
by Administrators Qynapse | Oct 3, 2018 | News
Qynapse is pleased to announce the signing of a partnership agreement with AG Mednet, the leading provider of medical trials data management services, for the use of its Judi imaging adjudication system. The partnership formed with AG Mednet will secure Qynapse’s...
